The Seattle Times | March 14, 2023
Health officials say fentanyl test strips could help prevent accidental overdoses, but they're currently illegal. Caleb Banta-Green, PhD, is quoted.
The Seattle Times | March 14, 2023
Health officials say fentanyl test strips could help prevent accidental overdoses, but they're currently illegal. Caleb Banta-Green, PhD, is quoted.
Memory & Brain Wellness Center | March 9, 2023
Jeff Iliff, PhD, is using data from the Seattle Longitudinal Study (SLS) created by Sherry Willis, PhD, and the late Warner Schaie, PhD, to investigate the link between sleep and dementia risk.
UW Magazine | March 4, 2023
Schools are on the front lines of the mental health crisis and need trained social workers and the resources to help kids who are suffering, write Eric Bruns, PhD, and Jennifer Stuber, PhD.
The UW Daily | March 2, 2023
Starting in 2023, four advanced registered nurse practitioner (ARNP) fellows will be trained in psychiatry at the UW Medical Center. The training will include inpatient, outpatient, telehealth consultation, integrated psychiatric care, and rotations at primary care clinics.
KIRO 7 | March 1, 2023
Richard Ries says that right now in Washington, about 1-2% of people entering treatment have xylazine in their systems. The sedative is an animal tranquilizer that officials say is being mixed with drugs like fentanyl and heroin.
Department news | February 28, 2023
Congratulations to the recipients of our latest round of Staff Scholarship Awards! Funded by department and philanthropic funds, these awards support professional development of classified and professional staff who work in our department.
Department news | February 28, 2023
We are thrilled to announce that our department has been awarded a five-year grant from the National Institute of Mental Health for a new practice-based Suicide Care Research Center directed by Katherine Ann (Kate) Comtois, PhD, MPH.
Department news | February 28, 2023
Myra Parker, JD, MPH, PhD, with the support of the Centers for Disease Control & Prevention and the National Network of Public Health Institutes, has produced an Indigenous Evaluation Toolkit.
Department news | February 28, 2023
Marco Pravetoni, PhD, recently traveled to DC to represent the potential we have to make a difference in one of the most compelling human crises our country is facing -- opioid use disorder and related overdoses.
KIMA | February 27, 2023
The DEA is sending out a warning as a new "zombie drug" called Xylazine has made its way into the state. Richard Ries, MD, FAPA, FASM, is quoted.